Semmax Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Semmax Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.9K	Sell	28 -12	-30%	-$5.02K	﹤0.01%	248
2025 Q1	$16.1K	Hold	40	–	–	﹤0.01%	211
2024 Q4	$21.3K	Hold	40	–	–	0.01%	188
2024 Q3	$21.6K	Buy	40 +12	+43%	+$7.1K	0.01%	179
2024 Q2	$16.9K	Buy	28 +11	+65%	+$6.3K	0.01%	208
2024 Q1	$10K	Hold	17	–	–	﹤0.01%	207
2023 Q4	$9.16K	Hold	17	–	–	﹤0.01%	217
2023 Q3	$7.57K	Buy	+17	New	+$9.06K	﹤0.01%	207
2022 Q4	$10K	Hold	17	–	–	﹤0.01%	172
2022 Q3	$8K	Hold	17	–	–	﹤0.01%	172
2022 Q2	$10K	Hold	17	–	–	﹤0.01%	167
2022 Q1	$10K	Hold	17	–	–	﹤0.01%	189
2021 Q4	$11K	Hold	17	–	–	﹤0.01%	174
2021 Q3	$10K	Hold	17	–	–	﹤0.01%	173
2021 Q2	$9K	Hold	17	–	–	﹤0.01%	176
2021 Q1	$8K	Sell	17 -20	-54%	-$9.55K	﹤0.01%	194
2020 Q4	$17K	Buy	37 +20	+118%	+$9.38K	0.01%	150
2020 Q3	$8K	Hold	17	–	–	﹤0.01%	158
2020 Q2	$6K	Hold	17	–	–	﹤0.01%	182
2020 Q1	$5K	Hold	17	–	–	﹤0.01%	187
2019 Q4	$6K	Hold	17	–	–	﹤0.01%	204
2019 Q3	$5K	Hold	17	–	–	﹤0.01%	213
2019 Q2	$5K	Hold	17	–	–	﹤0.01%	226
2019 Q1	$5K	Hold	17	–	–	﹤0.01%	360
2018 Q4	$4K	Buy	+17	New	+$3.99K	﹤0.01%	369

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Semmax Financial Advisors's TMO Position: Q2 2025 in Review

Semmax Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 30% in Q2 2025, selling an estimated $5.02K and leaving 28 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #248.

Semmax Financial Advisors first reported a position in TMO in Q4 2018 and has held it in 25 quarters since. The position peaked at $21.6K in Q3 2024. 2,459 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Semmax Financial Advisors held 28 shares of Thermo Fisher Scientific worth $12.9K as of Q2 2025.
Semmax Financial Advisors sold 12 Thermo Fisher Scientific shares in Q2 2025, an estimated $5.02K.
Thermo Fisher Scientific made up ﹤0.01% of Semmax Financial Advisors's portfolio in Q2 2025, its #248 holding.
Semmax Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 25 quarters since.
Semmax Financial Advisors's Thermo Fisher Scientific position peaked at $21.6K in Q3 2024.
2,459 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.